Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis: A case- control study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 6, 1997, Pages 1171-1177

  Iribarren, Carlos ^a   Folsom, Aaron R ^a   Jacobs Jr , David R ^a   Gross, Myron D ^a   Belcher, John D ^a   Eckfeldt, John H ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Atherosclerosis; Autoantibodies; Cardiovascular disease; LDL oxidation

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ASCORBIC ACID; AUTOANTIBODY; BETA CAROTENE; LOW DENSITY LIPOPROTEIN; LYCOPENE; RETINOL;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CAROTID ARTERY OBSTRUCTION; DIET SUPPLEMENTATION; DISEASE PREDISPOSITION; FEMALE; HUMAN; LIPID OXIDATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL; VITAMIN INTAKE;

EID: 0030912927     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.6.1171     Document Type: Article

References (66)

1. Halliwell B. Oxidants and human disease: some new concepts. FASEDJ. 1987;l:358-364.
2. Ames BN. Endogenous oxidative DNA damage, aging and cancer. Free Radie Res Commun. 1989;7:1231-1238.
3. Gutteridge JMC. Free radicals in disease processes: a compilation of causes and consequences. Free Radie Res Commun. 1993;19: 141-158.
4. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engt J Med. 1989:320:915-924.
5. Kita T. Nagano Y, Yokode M, Ishii K, Kume N, Ooshima A, Yoshida H, Kawai C. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipemic rabbit, an animal model for familial hypercholesterolemia. Proc Nail Acad Sci USA. 1987; 84:5928-5931.
6. Aviram M. Low density lipoprotein modification by cholesterol oxidase induces enhanced uptake and cholesterol accumulation in cells. J Biol Chem. 1992:267:218-225.
7. Esterbauer H, Gebicki J, Puhl H, Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med. 1992; 13:341 -390.
8. Offermann MK, Medford RM. Antioxidants and atherosclerosis: a molecular perspective. Heart Dis Stroke. 1994;3:52-57.
9. Gey KF, Puska P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in crosscultural epidemiology. Am J Clin Nutr. 1991;53:326S-331S.
10. Armstrong BK, Mann JI, Adelstein AM, Eskin F. Commodity consumption and ischemic heart disease mortality, with special reference to dietary practices. J Chron Dis. 1975;28:455-469.
11. Bellizzi MC, Franklin MF, Duthie GG, James WP. Vitamin E and coronary heart disease: the European paradox. Eur J Clin Nutr, 1994; 48:822-831.
12. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willen WC. Vitamin E consumption and the risk of coronary heart disease in women. N Engl J Med. 1993:328:1444-1449.
13. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease. N Engl J Med. 1993;328:1450-1456.
14. Todd S, Woodward M, Bolton-Smith C. An investigation of the relationship between antioxidant vitamin intake and coronary heart disease in men and women using logistic regression. J Clin Epidemiol. 1995:48:307-316.
15. Riemersma RA, Wood DA, Macintyre CC, Elton RA, Gey KF, Oliver MF. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet. 1991;337:l-5.
16. Luoma PV, Nayha S, Sikkila K, Hassi J. High serum alpha-tocopherol, albumin, selenium and cholesterol, and low mortality from coronary heart disease in northern Finland. J Intern Med. 1995;237: 49-54.
17. Kardinaal AFM, Kok FJ, Ringstad J, Gómez-Aracena J, Mazaev VP, Kohlmeier L, Martin BC, Aro A, Kark JD, Delgado-Rodriguez M, Riemersma RA, Huttunen LK, Martín-Moreno JM. Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC study. Lancet. 1993:342:1379-1384.
18. Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssönen K, Palinski W, Witztum JL. Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet. 1992:339:883-887.
19. Maggi E, Chiesa R, Melissano G, Castellano R, Astore D, Grossi A, Finardi G, Bellomo G. LDL oxidation in patients with severe carotid atherosclerosis: a study of in vitro and in vivo oxidation markers. Arteriosder Thromb. 1994;14:1892-1899.
20. Holvoet P, Ferez G, Zhao Z, Bromvers E, Bernar H, Collen D. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease. J Clin Invest. 1995;95:2611-2619.
21. Salonen JT, Salonen R, Penttila I, Herranen J, Jauhiainen M, Kantola M, Lappetelainen R, Maenpaa P, Alfthan G, Puska P. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and risk of death from coronary heart disease. Am J Cardiol. 1985;56:226-231.
22. Kok FJ, de Bruijn AM, Vermeeren R, Hofman A, VanLaar A, de Bruin M, Hermus RTJ, Valkenberg HA. Serum selenium, vitamin antioxidants and cardiovascular mortality: a 9-year follow-up study in the Netherlands. Am J Clin Nutr. 1987:45:462-468.
23. Fehily A, Yarnell J, Sweetnam P, Elwood P. Diet and incident ischaemic heart disease: the Caerphilly Study. Br J Nutr. 1993;69: 303-314.
24. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engt J Med. 1994; 330:1029-1035.
25. Walldius G, Erikson U, Olsson AG, Bergstrand L, Hådell K, Johansson J, Kaijser L, Lassvik C, Mölgaard J, Nilsson S, Schäfer-Elinder L, Stenport G, Holme I. The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST). Am J Cardiol. 1994;74:875-883.
26. Li J-Y, Taylor PR, Li B, Dawsey S, Wang G-Q, Ershow AG, Guo W, Liu S-F, Yang CS, Shen Q, Wang W. Mark SD, Zou X-N, Greenwald P, Wu Y-P, Blot WJ. Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. J Natl Cancer Inst. 1993;85:1492-1498.
27. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willett W, Peto R. Lack of effect of long-term supplementation with betacarotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996;334:1145-1149.
28. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996;347:78I-786.
29. Kritchevsky SB, Shimakawa T, Tell GS, Dennis B, Carpenter M, Eckfeldt JH, Peacher-Ryan H, Heiss G. Dietary antioxidants and carotid artery wall thickness: the ARIC study. Circulation. 1995;92: 2142-2150.
30. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. Am J Epidemiol. 1989;129: 687-702.
31. Bond MG, Barnes R, Riley WA, Wilmoth SK, Chambless LE, Howard G, Owens B. High resolution B-mode ultrasound scanning methods in the Atherosclerosis Risk in Communities study (ARIC). J Neuroimaging. 1991 ; 1:68-73.
32. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimai plus medial thickness of arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74:1399-1406.
33. Riley WA, Barnes R, Bond MG, Evans GW, Chambless L, Heiss G. High resolution B-mode ultrasound reading methods in the Atherosclerosis Risk in Communities study (ARIC). J Neuroimaging. 1991; 1:168-172.
34. Heiss G, Sharret AR, Barnes R, Chambless LE, Szklo M, Alzola C, and the ARIC Investigators. Case-control analysis of atherosclerosis and established risk factors. Am J Epidemiol. 1991 ; 134:250-256.
35. Bieri JG, Brown ED, Smith JC. Determination of individual carotenoids in human plasma by high performance chromatography. J Liq Chromatogr. 1985;8:473-484.
36. Craft NE, Brown ED, Smith JD. Effects of storage and handling conditions on concentrations of individual carotenoids, retinol and tocopherol in plasma. Clin Chem. 1988;34:44-48.
37. Belcher JD, Balla J, Balla G, Jacobs DR Jr, Gross MD, Jacob HS, Vercelloti GM. Vitamin E, LDL, and endothelium: brief oral supplementation prevents oxidized LDL-mediated vascular injury in vivo. Arterioscler Thromb. 1993;13:1779-1789.
38. Palinski W, Ylä-Herttuala S, Rosenfeld ME, Butler SW, Socher SA, Parthasarathy S, Curtiss LK, Witztum JL. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis. 1990;10: 325-335.
39. Palinski W, Rosenfeld ME, Ylä-Herttuala S, Gunner GC, Socher SS, Butler SW, Parthasarathy S, Steinberg D, Witztum JL. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA. 1989;86:1372-1376.
40. Willen W, Sampson L, Stampfer M, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985; 122:51-65.
41. Consumer and Food Economics Institute. Composition of Foods: Ran; Processed, Prepared. Washington, DC: US Dept of Agriculture; 1976-1993.
42. Romieu I, Stampfer M, Stryker W, Hernandez M, Kaplan L, Sober A, Rosner B, Willett WC. Food predictors of plasma beta-carotene and alpha-tocopherol: validation of a food frequency questionnaire. Am J Epidemiol. 1990;131:864-876.
43. McLaughlin P, Weihraugh J. Vitamin E content of foods. J Am Diet Assoc. 1979;75:647-665.
44. National Heart, Lung, and Blood Institute. ARIC manual of operations No. 8, Lipid and Lipoprotein Determinations, and No. 10, Clinical Chemistry Determinations. Chapel Hill, NC: ARIC Coordinating Center, School of Public Health, University of North Carolina; 1988.
45. Schlesselman JJ. Case-Control Studies: Design, Conduct, Analysis. New York, NY: Oxford University Press; 1982:182. Monographs in Epidemiology and Biostatistics.
46. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analysis. Am J Epidemiol. 1986; 124:17-27.
47. SAS Institute Inc. SAS/STAT User's Guide, Version 6.09. 4th ed. Cary, NG: SAS Institute Inc; 1994.
48. Morris DL, Kritchevsky SB, Davis CE. Serum carotenoids and coronary heart disease: the Lipid Research Clinics Coronary Primary Prevention Trial. JAMA. 1994;272:1439-1441.
49. DiMascio P, Murphy ME, Sies H. Antioxidant defense systems: the role of carotenoids, tocopherols and thiols. Am J Clin Nutr. 1991 ;53: 194S-200S.
50. Kostic D, White WS, Oison JA. Intestinal absorption, serum clearance, and interactions between lutein and β-carotene when administered to human adults in separate or combined doses. Am J Clin Nutr. 1995;62:604-610.
51. Martini MC, Campbell DR, Gross MD, Grandits GA, Potter JD, Slavin JL. Plasma carotenoids as biomarkers of vegetable intake: the University of Minnesota Cancer Prevention Research Unit Feeding Studies. Cancer Epidemiol Biomarkers Prev. 1995;4: 491-496.
52. Cominacini L, Garbin U, Pastorino AM, Davoli A, Campagnola M, De Santis A, Pasini C, Faccini GB, Trevisan MT, Bertozzo L, Pasini F, Lo Cascio V. Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease. Atherosclerosis. 1993;99:63-70.
53. Regnström J, Nilsson J, Tornvall P, Ländern C, Hamsten A. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet. 1992;339:1183-1186.
54. Van Hinsbergh VW, Scheffer M, Havekes L, Kempen HJ. Role of endothelial cells and their products in the modification of low-density lipoproteins. Biochim Biopliys Acta. 1986;878:49-64.
55. Frei B, Gaziano M. Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation. J Lipid Res. 1993;34:2135-2145.
56. Jialal I, Fuller CJ, Huet BA. The effect of alpha-tocopherol supplementation on LDL oxidation: a dose-response study. Arterioscler Tliromb Vase Biol. 1995:15:190-198.
57. Estebauer H, Slriegl G, Puhl H, Oberreither-S, Rotheneder M. The role of vitamin E and carotenoids in preventing oxidation of low density lipoprotein. Ann N YAcad Sci. 1989;570:254-267.
58. Parthasarathy S, Khoo JC, Miller E, Barnett J, Witztum JL, Steinberg D. Low density lipoprotein rich in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis. Proc Natl Acad Sci US A. 1990;87:3894-3898.
59. Stocker R, Bowry VW, Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha tocopherol. Proc Nail Acad Sci U S A. 1991;88:1646-1650.
60. Bergmark C, Wu R, de Faire U, Lefvert AK, Swedenborg J. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arterioscler Thromb Vase Biol. 1995;15:441-445.
61. Van de Vijver LPL, Steyger R, Van Poppel G, Boer JMA, Kruijssen DACM, Seidell JC, Princen HMG. Autoantibodies against MDALDL in subjects with severe and minor atherosclerosis and healthy population controls. Atherosclerosis. 1996;122:245-253.
62. Salonen JT, Salonen R, Seppanen K, Kantola M, Parviainen M, Alfthan G, Maenpaa PH, Taskinen E, Rauramaa R. Relationship of serum selenium and antioxidants to plasma lipoproteins: platelet aggregability and prevalent ischaemic heart disease in eastern Finnish men. Atherosclerosis. 1988;70:155-160.
63. Hense HW, Slender M, Bors W, Keil U. Lack of an association between serum vitamin E and myocardial infarction in a population with high vitamin E levels. Atherosclerosis. 1993;103:21-28.
64. Duthie GG, Beattie JAG, Arthur JR, Franklin M, Morrice PC, James PT. Blood antioxidants and indices of lipid peroxidation in subjects with angina pectoris. Nutrition. 1994;10:313-316.
65. Grundy SM. Oxidized LDL and atherogenesis: relation to risk factors for coronary heart disease. Clin Cardiol. 1993;16(suppl I):I-3-I-5.
66. Dejager S, Bruckert E, Chapman MJ. Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia. J Lipid Res. 1993:34:295-308.